13F Portfolios

TORRAY INVESTMENT PARTNERS LLC 13F: Quarter-over-Quarter Portfolio Changes

TORRAY INVESTMENT PARTNERS LLC reported a disclosed portfolio value of approximately $741.3 million in its latest SEC Form 13F-HR filing for Q2 2026, up 8.7% quarter on quarter. Over the quarter, the manager initiated 8 new positions, bought more shares in 33 holdings, trimmed 31 holdings, and exited 5 positions.

TORRAY INVESTMENT PARTNERS LLC's top buy was a new stake in Alphabet INC (UNKNOWN) , equal to 3.2% of the disclosed portfolio. Its top sell was Hewlett Packard Ent Ser C Conv (HPE 7.625 09/01/27) . The manager exited the position completely after it had accounted for 3.5% of the previous portfolio.

New PositionsQ2 2026

Securities disclosed for the first time in Q2 2026 that were not present in the prior 13F-HR filing.

TORRAY INVESTMENT PARTNERS LLC new positions in Q2 2026, representing first-time disclosed long equity stakes
CompanyTickerInitial Portfolio WeightHistory
ALPHABET INCUNKNOWN3.2%History →
KKR SERIES D CONV 6.25SYN_48251W5003.1%Holders →
HEWLETT PACKARD ENT SER C CONVSYN_42824C2082.9%Holders →
ACCENTURE PLC IRELANDACN2.8%History →
ZOOM COMMUNICATIONS INCZM0.3%Holders →
NOVANTA INCNOVT0.2%Holders →
UNITEDHEALTH GROUP INCUNH0.0%Holders →
BANK OF NY MELLON CORPBK0.0%Holders →

Top BuysQ2 2026

Showing the top 10 buys among 33 existing positions where the manager bought more shares in Q2 2026. Ranked by portfolio-weight impact, with the percentage of additional shares shown separately.

TORRAY INVESTMENT PARTNERS LLC top buys in existing positions in Q2 2026
CompanyTickerPortfolio Weight ChangeMore SharesHistory
KLA CORPKLAC+0.5%+737.5%Holders →
VANGUARD INDEX FDSVUG+-0.1%+151.4%Holders →
VERASTEM INCVSTM+0.0%+59.7%Holders →
COMCAST CORP NEWCMCSA+0.5%+55.5%History →
ISHARES TRIWF+-0.1%+42.3%Holders →
SYNDAX PHARMACEUTICALS INCSNDX+0.0%+27.6%Holders →
NEXTERA ENERGY INCNEE+0.1%+19.1%Holders →
CONSTELLATION ENERGYCEG+-0.2%+17.1%History →
RYAN SPECIALTY HOLDINGS INCRYAN+0.1%+14.5%Holders →
BLACKSTONE INCBX+0.2%+14.3%History →

Top SellsQ2 2026

Showing the top 10 sells among 31 existing positions where the manager sold shares in Q2 2026. Ranked by portfolio-weight impact. Full exits are listed separately.

TORRAY INVESTMENT PARTNERS LLC top sells in existing positions in Q2 2026
CompanyTickerPortfolio Weight ChangeShares SoldHistory
JPMORGAN CHASE & COJPM-1.5%92.4%Holders →
MORGAN STANLEYMS-0.7%92.3%Holders →
MICROSOFT CORPMSFT-2.4%53.5%Holders →
ROCKET LABSYN_773122106-0.0%50.0%Holders →
TEXAS INSTRS INCTXN-0.8%45.6%Holders →
HOME DEPOT INCHD-0.0%22.4%Holders →
PHILLIPS 66PSX-1.1%16.5%Holders →
FABRINETFN-0.1%15.2%Holders →
BLOOM ENERGY CORPBE1.0%12.4%Holders →
JACK HENRY & ASSOCIATESJKHY-0.1%11.9%Holders →

Full ExitsQ2 2026

Positions present in the prior 13F-HR filing that no longer appear in Q2 2026.

TORRAY INVESTMENT PARTNERS LLC full exits in Q2 2026
CompanyTickerLast-Reported Portfolio Weight
HEWLETT PACKARD ENT SER C CONVHPE 7.625 09/01/273.5%
KKR SERIES D CONV 6.25KKR 6.25 03/01/28 D2.8%
HURON CONSULTING GROUP INCHURN0.3%
QUALYS INCQLYS0.2%
HONEYWELL INTERNATIONAL INCHON0.0%
Latest

Net Portfolio Value ChangeQ2 2026

  • $0.7B
    Prior quarter
  • $0.7B
    Current quarter
  • +$0.1B
    Net delta
  • +8.7%
    % change

Methodology & FAQ

How TORRAY INVESTMENT PARTNERS LLC Quarterly Changes Are Computed

All deltas are sourced from sequential SEC Form 13F-HR filings for TORRAY INVESTMENT PARTNERS LLC: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description, including how confidential treatment filings are handled, is documented in the Methodology.

What stocks did TORRAY INVESTMENT PARTNERS LLC buy in Q2 2026?

In Q2 2026, TORRAY INVESTMENT PARTNERS LLC initiated 8 new positions (ALPHABET INC (UNKNOWN), KKR SERIES D CONV 6.25 (SYN_48251W500), HEWLETT PACKARD ENT SER C CONV (SYN_42824C208), ACCENTURE PLC IRELAND (ACN), ZOOM COMMUNICATIONS INC (ZM), NOVANTA INC (NOVT), UNITEDHEALTH GROUP INC (UNH), BANK OF NY MELLON CORP (BK)); bought more shares of KLA CORP (KLAC), VANGUARD INDEX FDS (VUG), VERASTEM INC (VSTM), COMCAST CORP NEW (CMCSA), ISHARES TR (IWF) (the largest 5 of 33 adds).

What stocks did TORRAY INVESTMENT PARTNERS LLC sell in Q2 2026?

In Q2 2026, TORRAY INVESTMENT PARTNERS LLC fully sold 5 positions (HEWLETT PACKARD ENT SER C CONV (HPE 7.625 09/01/27), KKR SERIES D CONV 6.25 (KKR 6.25 03/01/28 D), HURON CONSULTING GROUP INC (HURN), QUALYS INC (QLYS), HONEYWELL INTERNATIONAL INC (HON)); reduced holdings in JPMORGAN CHASE & CO (JPM), MORGAN STANLEY (MS), MICROSOFT CORP (MSFT), ROCKET LAB (SYN_773122106), TEXAS INSTRS INC (TXN) (the largest 5 of 31 reductions).

Which positions did TORRAY INVESTMENT PARTNERS LLC initiate in Q2 2026?

TORRAY INVESTMENT PARTNERS LLC established 8 new positions in Q2 2026: ALPHABET INC (UNKNOWN, 3.2%), KKR SERIES D CONV 6.25 (SYN_48251W500, 3.1%), HEWLETT PACKARD ENT SER C CONV (SYN_42824C208, 2.9%), ACCENTURE PLC IRELAND (ACN, 2.8%), ZOOM COMMUNICATIONS INC (ZM, 0.3%), NOVANTA INC (NOVT, 0.2%), UNITEDHEALTH GROUP INC (UNH, 0.0%), BANK OF NY MELLON CORP (BK, 0.0%).

Which existing positions saw the largest allocation increases for TORRAY INVESTMENT PARTNERS LLC in Q2 2026?

Of 33 existing positions with share-count increases in Q2 2026, the largest were: KLA CORP (KLAC, +0.5% weight, +737.5% shares), VANGUARD INDEX FDS (VUG, +-0.1% weight, +151.4% shares), VERASTEM INC (VSTM, +0.0% weight, +59.7% shares), COMCAST CORP NEW (CMCSA, +0.5% weight, +55.5% shares), ISHARES TR (IWF, +-0.1% weight, +42.3% shares), SYNDAX PHARMACEUTICALS INC (SNDX, +0.0% weight, +27.6% shares), NEXTERA ENERGY INC (NEE, +0.1% weight, +19.1% shares), CONSTELLATION ENERGY (CEG, +-0.2% weight, +17.1% shares), RYAN SPECIALTY HOLDINGS INC (RYAN, +0.1% weight, +14.5% shares), BLACKSTONE INC (BX, +0.2% weight, +14.3% shares).

Which positions did TORRAY INVESTMENT PARTNERS LLC fully exit in Q2 2026?

TORRAY INVESTMENT PARTNERS LLC fully exited 5 positions in Q2 2026: HEWLETT PACKARD ENT SER C CONV (HPE 7.625 09/01/27, last-reported weight 3.5%), KKR SERIES D CONV 6.25 (KKR 6.25 03/01/28 D, last-reported weight 2.8%), HURON CONSULTING GROUP INC (HURN, last-reported weight 0.3%), QUALYS INC (QLYS, last-reported weight 0.2%), HONEYWELL INTERNATIONAL INC (HON, last-reported weight 0.0%).

Which existing positions saw the largest allocation reductions for TORRAY INVESTMENT PARTNERS LLC in Q2 2026?

Of 31 existing positions with share-count reductions in Q2 2026, the largest were: JPMORGAN CHASE & CO (JPM, -1.5% weight, -92.4% shares), MORGAN STANLEY (MS, -0.7% weight, -92.3% shares), MICROSOFT CORP (MSFT, -2.4% weight, -53.5% shares), ROCKET LAB (SYN_773122106, -0.0% weight, -50.0% shares), TEXAS INSTRS INC (TXN, -0.8% weight, -45.6% shares), HOME DEPOT INC (HD, -0.0% weight, -22.4% shares), PHILLIPS 66 (PSX, -1.1% weight, -16.5% shares), FABRINET (FN, -0.1% weight, -15.2% shares), BLOOM ENERGY CORP (BE, 1.0% weight, -12.4% shares), JACK HENRY & ASSOCIATES (JKHY, -0.1% weight, -11.9% shares).

Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?

No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.